C126H134F3N35O11S — CID 157066875
2-(benzylamino)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;tert-butyl 4-[[5-(6-ethyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]carbamoyl]piperidine-1-carboxylate;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide (PubChem CID 157066875) has the molecular formula C126H134F3N35O11S and a molecular weight of 2403.75 g/mol. Its IUPAC name is 2-(benzylamino)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;tert-butyl 4-[[5-(6-ethyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]carbamoyl]piperidine-1-carboxylate;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide.
| Compound Name | 2-(benzylamino)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;tert-butyl 4-[[5-(6-ethyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]carbamoyl]piperidine-1-carboxylate;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide |
|---|---|
| PubChem CID | 157066875 |
| Molecular Formula | C126H134F3N35O11S |
| Molecular Weight | 2403.75 g/mol |
| Exact Mass | 2402.07 |
| IUPAC Name | 2-(benzylamino)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;tert-butyl 4-[[5-(6-ethyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]carbamoyl]piperidine-1-carboxylate;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide |
| SMILES | CCc1ccc2nc(-c3[nH]ncc3NC(=O)C3CCN(C(=O)OC(C)(C)C)CC3)[nH]c2c1.Cc1nc(C(F)(F)F)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)s1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1CCN(c2ncccn2)CC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccccc1-c1ccccc1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccccc1NCc1ccccc1 |
| InChI | InChI=1S/C29H29N7O2.C28H26N6O2.C25H29N9O2.C23H30N6O3.C21H20F3N7O2S/c37-29(22-8-4-5-9-23(22)30-17-20-6-2-1-3-7-20)34-26-18-31-35-27(26)28-32-24-11-10-21(16-25(24)33-28)19-36-12-14-38-15-13-36;35-28(22-9-5-4-8-21(22)20-6-2-1-3-7-20)32-25-17-29-33-26(25)27-30-23-11-10-19(16-24(23)31-27)18-34-12-14-36-15-13-34;35-24(18-4-8-34(9-5-18)25-26-6-1-7-27-25)31-21-15-28-32-22(21)23-29-19-3-2-17(14-20(19)30-23)16-33-10-12-36-13-11-33;1-5-14-6-7-16-17(12-14)26-20(25-16)19-18(13-24-28-19)27-21(30)15-8-10-29(11-9-15)22(31)32-23(2,3)4;1-11-26-18(21(22,23)24)17(34-11)20(32)29-15-9-25-30-16(15)19-27-13-3-2-12(8-14(13)28-19)10-31-4-6-33-7-5-31/h1-11,16,18,30H,12-15,17,19H2,(H,31,35)(H,32,33)(H,34,37);1-11,16-17H,12-15,18H2,(H,29,33)(H,30,31)(H,32,35);1-3,6-7,14-15,18H,4-5,8-13,16H2,(H,28,32)(H,29,30)(H,31,35);6-7,12-13,15H,5,8-11H2,1-4H3,(H,24,28)(H,25,26)(H,27,30);2-3,8-9H,4-7,10H2,1H3,(H,25,30)(H,27,28)(H,29,32) |
| InChIKey | ABZAAXMWBFTVOQ-UHFFFAOYSA-N |
| XLogP | 19.71 |
| TPSA | 565.66 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 176 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2403.75 |
| LogP ≤ 5 | 19.71 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 31 |